These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26343498)

  • 1. In vivo efficacy and toxicity evaluation of polycaprolactone nanoparticles and aluminum based admixture formulation as vaccine delivery system.
    Bansal V; Kumar M; Bhardwaj A; Brahmne HG; Singh H
    Vaccine; 2015 Oct; 33(42):5623-5632. PubMed ID: 26343498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of synergistic effect of biodegradable polymeric nanoparticles and aluminum based adjuvant for improving vaccine efficacy.
    Bansal V; Kumar M; Dalela M; Brahmne HG; Singh H
    Int J Pharm; 2014 Aug; 471(1-2):377-84. PubMed ID: 24939616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of nanoadjuvant with poly-ε-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity.
    Prashant CK; Bhat M; Srivastava SK; Saxena A; Kumar M; Singh A; Samim M; Ahmad FJ; Dinda AK
    Int J Nanomedicine; 2014; 9():937-50. PubMed ID: 24611010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses.
    Kaur A; Jyoti K; Rai S; Sidhu R; Pandey RS; Jain UK; Katyal A; Madan J
    J Microencapsul; 2016 May; 33(3):263-73. PubMed ID: 27056086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of excipients on in vitro release and in vivo performance of tetanus toxoid loaded polymer particles.
    Katare YK; Panda AK
    Eur J Pharm Sci; 2006 Jun; 28(3):179-88. PubMed ID: 16517132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
    Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced mucosal immune responses against tetanus toxoid using novel delivery system comprised of chitosan-functionalized gold nanoparticles and botanical adjuvant: characterization, immunogenicity, and stability assessment.
    Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
    J Pharm Sci; 2014 Nov; 103(11):3448-3456. PubMed ID: 25219511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological evaluation of chitosan nanoparticles loaded with tetanus toxoid.
    Ghalavand M; Saadati M; Ahmadi A; Abbasi E; Salimian J
    Bratisl Lek Listy; 2018; 119(2):71-74. PubMed ID: 29455539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quillaja saponaria extract as mucosal adjuvant with chitosan functionalized gold nanoparticles for mucosal vaccine delivery: stability and immunoefficiency studies.
    Barhate G; Gautam M; Gairola S; Jadhav S; Pokharkar V
    Int J Pharm; 2013 Jan; 441(1-2):636-42. PubMed ID: 23117021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
    Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
    Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-tetanus immune response of neonatal mice is augmented by retinoic acid combined with polyriboinosinic:polyribocytidylic acid.
    Ma Y; Ross AC
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13556-61. PubMed ID: 16157890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-based immunopotentiation via tetanus toxoid-loaded gelatin and aminated gelatin nanoparticles.
    Sudheesh MS; Vyas SP; Kohli DV
    Drug Deliv; 2011 Jul; 18(5):320-30. PubMed ID: 21351824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.
    Katare YK; Panda AK
    Vaccine; 2006 Apr; 24(17):3599-608. PubMed ID: 16513224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poly(epsilon-caprolactone)/poly(ethylene glycol)/poly(epsilon-caprolactone) nanoparticles: preparation, characterization, and application in doxorubicin delivery.
    Gou M; Zheng X; Men K; Zhang J; Zheng L; Wang X; Luo F; Zhao Y; Zhao X; Wei Y; Qian Z
    J Phys Chem B; 2009 Oct; 113(39):12928-33. PubMed ID: 19736995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
    Singh J; Pandit S; Bramwell VW; Alpar HO
    Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to antigen adsorbed to aluminum hydroxide particles: Effects of co-adsorption of ALF or ALFQ adjuvant to the aluminum-antigen complex.
    Beck Z; Torres OB; Matyas GR; Lanar DE; Alving CR
    J Control Release; 2018 Apr; 275():12-19. PubMed ID: 29432824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.